NIRS for the Diagnosis of Myofascial Pelvic Pain
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- University of California, Los Angeles
- Study ID
- NCT07181447
- Status
- Recruiting
Conditions
- Myofascial Pelvic Pain
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Pelvic Floor Muscle Assessment by Near-Infrared Spectroscopy — DIAGNOSTIC_TESTThis study will develop and test an instrument to establish a normal range for near infrared spectroscopy (NIRS) optical changes associate with pelvic floor exercise in adult women based on the test-to test (intra-day) reliability of oxygen kinetics related to contraction of the pelvic floor muscle. We will establish the relationship between the quantitative NIRS data, the condition of Myofascial pelvic musculature and the symptomatology of MPP and related comorbidities. We will also evaluate prospectively the effectiveness of these data in predicting effective treatment modalities. Finally, we will optimize a training regime for non-specialists to allow this technique to be used in a variety of settings. The development of this device and validation of its relevance to diagnosis and treatment of MPP will provide effective care sooner and at a lower cost than current procedures. It will also reduce inequities in the availability of care to underserved populations.
Study Details
Myofascial Pelvic Pain (MPP) is an often-misdiagnosed condition affecting up to 26% of women during their lives and imposing enormous costs on national health care systems. It frequently involves comorbidities such as bladder, bowel, and sexual dysfunction. There are no quantitative measures that adequately guide the physician and accurate diagnosis typically requires an internal examination by a tertiary specialist. This study will develop and test an instrument to establish a normal range for near infrared spectroscopy (NIRS) optical changes associate with pelvic floor exercise in adult women based on the test-to test (intra-day) reliability of oxygen kinetics related to contraction of the pelvic floor muscle. We will establish the relationship between the quantitative NIRS data, the condition of Myofascial pelvic musculature and the symptomatology of MPP and related comorbidities. We will also evaluate prospectively the effectiveness of these data in predicting effective treatment modalities. Finally, we will optimize a training regime for non-specialists to allow this technique to be used in a variety of settings. The development of this device and validation of its relevance to diagnosis and treatment of MPP will provide effective care sooner and at a lower cost than current procedures. It will also reduce inequities in the availability of care to underserved populations by providing an inexpensive, reliable and easily available method for a variety of providers to address MPP.
Key Dates
- Start date
- Jan 23, 2025
- Status verified
- Sep 2025
- Primary completion
- Jul 1, 2026
- Completion
- Sep 1, 2026
Study Design
- Enrollment
- 110 participants (estimated)
Arms
- Arm: Control SubjectsWomen age 18 or older without pelvic pain or other genitourinary complaints
- Arm: Myofascial Pelvic Pain SubjectsWomen age 18 or older with pelvic floor muscle pain or tender points
Primary Outcome Measure
MPP Diagnosis [ Time Frame: 1 day ]
Central Contacts
- Keila Kimura310-794-5910
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UCLA Center for Women's Pelvic Health | Los Angeles | California | 90095 | 310-794-5910 Anne L Ackerman, MD PHD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Los Angeles, CA
Related Studies
- Transvaginal Electrical Stimulation for Myofascial Pelvic PainRecruiting · University of California, Los Angeles · Los Angeles, California
- Measuring Pelvic Floor Muscle Fitness Before and After TreatmentNot Yet Recruiting · University of California, Los Angeles · Los Angeles, California